Rheumatoid arthritis. Pathophysiology and implications for therapy.

[1]  H. Erlich,et al.  Shared molecular markers of genetic predisposition to seropositive rheumatoid arthritis. , 1990, Human immunology.

[2]  Obin,et al.  Endothelial interleukin-8: a novel inhibitor of leukocyte-endothelial interactions. , 1989, Science.

[3]  R. Shmerling,et al.  Prolonged improvement in refractory rheumatoid arthritis after antithymocyte globulin therapy of brief duration. , 1989, Arthritis and rheumatism.

[4]  P. Lipsky,et al.  The control of antibody production by immunomodulatory molecules. , 1989, Arthritis and rheumatism.

[5]  G. Moxley.  Immunoglobulin kappa genotype confers risk of rheumatoid arthritis among HLA-DR4 negative individuals. , 1989, Arthritis and rheumatism.

[6]  C. Morris,et al.  Oxygen free radicals, inflammation, and synovitis: and synovitis: the current status. , 1989, Annals of the rheumatic diseases.

[7]  A. Calin,et al.  Destructive arthritis, rheumatoid factor, and HLA-DR4. Susceptibility versus severity, a case-control study. , 1989, Arthritis and rheumatism.

[8]  H. Stockinger,et al.  Anti-CD4 antibody treatment of patients with rheumatoid arthritis: I. Effect on clinical course and circulating T cells. , 1989, Journal of autoimmunity.

[9]  G. Riethmüller,et al.  Anti-CD4 antibody treatment of patients with rheumatoid arthritis: II. Effect of in vivo treatment on in vitro proliferative response of CD4 cells. , 1989, Journal of autoimmunity.

[10]  D. Felson,et al.  Which traditional measures should be used in rheumatoid arthritis clinical trials? , 1989, Arthritis and rheumatism.

[11]  R. Sturrock,et al.  Urinary excretion of the hydroxypyridinium cross links of collagen in patients with rheumatoid arthritis. , 1989, Annals of the rheumatic diseases.

[12]  J. Eisman,et al.  Effects of low dose corticosteroids on bone mass in rheumatoid arthritis: a longitudinal study. , 1989, Annals of the rheumatic diseases.

[13]  J. Roudier,et al.  Susceptibility to rheumatoid arthritis maps to a T-cell epitope shared by the HLA-Dw4 DR beta-1 chain and the Epstein-Barr virus glycoprotein gp110. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[14]  M. Dougados,et al.  Assessment of efficacy and acceptability of low dose cyclosporin in patients with rheumatoid arthritis. , 1989, Annals of the rheumatic diseases.

[15]  Pike Mc.  Antiinflammatory effects of dietary lipid modification. , 1989 .

[16]  V. Bonagura,et al.  Seronegative rheumatoid arthritis, rheumatoid factor cross reactive idiotype expression, and hidden rheumatoid factors. , 1989, Annals of the rheumatic diseases.

[17]  P. Venables.  Infection and rheumatoid arthritis. , 1989, Current opinion in rheumatology.

[18]  J. Coligan,et al.  Isolation of CD4-CD8-mycobacteria-reactive T lymphocyte clones from rheumatoid arthritis synovial fluid , 1989, Nature.

[19]  S. Krane,et al.  Increases in levels of procollagenase messenger RNA in cultured fibroblasts induced by human recombinant interleukin 1 beta or serum follow c-jun expression and are dependent on new protein synthesis. , 1989, The Journal of clinical investigation.

[20]  H. Waldmann,et al.  Beneficial effect of monoclonal antibody to interleukin 2 receptor on activated T cells in rheumatoid arthritis. , 1989, Annals of the rheumatic diseases.

[21]  G. Moxley,et al.  DNA polymorphism of immunoglobulin kappa confers risk of rheumatoid arthritis. , 1989, Arthritis and rheumatism.

[22]  M. Sporn,et al.  Anchorage-independent growth of synoviocytes from arthritic and normal joints. Stimulation by exogenous platelet-derived growth factor and inhibition by transforming growth factor-beta and retinoids. , 1989, The Journal of clinical investigation.

[23]  P. B. Weisz,et al.  Control of angiogenesis with synthetic heparin substitutes. , 1989, Science.

[24]  B. Seed,et al.  Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. , 1989, Science.

[25]  M. Ziff,et al.  Endothelial cell activation induced by tumor necrosis factor and lymphotoxin. , 1989, The American journal of pathology.

[26]  S. Weiss.  Tissue destruction by neutrophils. , 1989, The New England journal of medicine.

[27]  P. Weber,et al.  The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. , 1989, The New England journal of medicine.

[28]  Sharp Jt.  Radiologic assessment as an outcome measure in rheumatoid arthritis. , 1989 .

[29]  C. Kwoh,et al.  Lack of correlation between the Steinbrocker staging of hand radiographs and the functional health status of individuals with rheumatoid arthritis. , 1989, Arthritis and rheumatism.

[30]  D. Isenberg,et al.  Raised serum IgG and IgA antibodies to mycobacterial antigens in rheumatoid arthritis. , 1989, Annals of the rheumatic diseases.

[31]  P. Guerne,et al.  Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis. , 1989, The Journal of clinical investigation.

[32]  T. Pincus,et al.  Active and latent forms of transforming growth factor beta activity in synovial effusions , 1989, The Journal of experimental medicine.

[33]  P. Venables,et al.  Factors predicting a poor life prognosis in rheumatoid arthritis: an eight year prospective study. , 1989, Annals of the rheumatic diseases.

[34]  S. Naides,et al.  Transient rheumatoid factor positivity in acute human parvovirus B19 infection. , 1988, Archives of internal medicine.

[35]  S. Wahl,et al.  Cyclosporin A in severe, treatment-refractory rheumatoid arthritis. A randomized study. , 1988, Annals of internal medicine.

[36]  T. Pincus,et al.  Formal education level as a significant marker of clinical status in rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[37]  G. Firestein,et al.  Cytokines in chronic inflammatory arthritis. I. Failure to detect T cell lymphokines (interleukin 2 and interleukin 3) and presence of macrophage colony-stimulating factor (CSF-1) and a novel mast cell growth factor in rheumatoid synovitis , 1988, The Journal of experimental medicine.

[38]  J. Gamble,et al.  Endothelial adhesiveness for blood neutrophils is inhibited by transforming growth factor-beta. , 1988, Science.

[39]  Y. Okada,et al.  The precursor of a metalloendopeptidase from human rheumatoid synovial fibroblasts. Purification and mechanisms of activation by endopeptidases and 4-aminophenylmercuric acetate. , 1988, The Biochemical journal.

[40]  D. Carson,et al.  Effect of neuropeptides on production of inflammatory cytokines by human monocytes , 1988 .

[41]  G. Kingsley,et al.  The preferential accumulation of helper‐inducer T lymphocytes in inflammatory lesions: evidence for regulation by selective endothelial and homotypic adhesion , 1988, European journal of immunology.

[42]  C. Spritzer,et al.  Early detection of carpal erosions in patients with rheumatoid arthritis: a pilot study of magnetic resonance imaging. , 1988, The Journal of rheumatology.

[43]  G. Silverman,et al.  Idiotypic and subgroup analysis of human monoclonal rheumatoid factors. Implications for structural and genetic basis of autoantibodies in humans. , 1988, The Journal of clinical investigation.

[44]  C. Sledge,et al.  Repeat radiation synovectomy with dysprosium 165-ferric hydroxide macroaggregates in rheumatoid knees unresponsive to initial injection. , 1988, Arthritis and rheumatism.

[45]  P. Hannonen,et al.  Antibodies against native type II collagen do not precede the clinical onset of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[46]  A. Roberts,et al.  Transforming growth factor-beta is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation. , 1988, Journal of immunology.

[47]  B. Polla,.  A role for heat shock proteins in inflammation? , 1988, Immunology today.

[48]  W. Cole,et al.  Autoantibodies to type II collagen: occurrence in rheumatoid arthritis, other arthritides, autoimmune connective tissue diseases, and chronic inflammatory syndromes. , 1988, Annals of the rheumatic diseases.

[49]  N. Miyasaka,et al.  Augmented interleukin-1 production and HLA-DR expression in the synovium of rheumatoid arthritis patients. Possible involvement in joint destruction. , 1988, Arthritis and rheumatism.

[50]  J. Roudier,et al.  The Epstein‐Barr Virus Glycoprotein gp110, a Molecular Link between HLA DR4, HLA DR1, and Rheumatoid Arthritis , 1988, Scandinavian journal of immunology.

[51]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[52]  J. Dayer,et al.  Diminished IL-2-induced gamma-interferon production by unstimulated peripheral-blood lymphocytes in rheumatoid arthritis. , 1988, British journal of rheumatology.

[53]  M. Dougados,et al.  Cyclosporin in rheumatoid arthritis: a double blind, placebo controlled study in 52 patients. , 1988, Annals of the rheumatic diseases.

[54]  S. Krane,et al.  Clonal dominance among T-lymphocyte infiltrates in arthritis. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[55]  I. Cohen,et al.  Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis , 1988, Nature.

[56]  J. Axford,et al.  REDUCED B-CELL GALACTOSYLTRANSFERASE ACTIVITY IN RHEUMATOID ARTHRITIS , 1987, The Lancet.

[57]  T. Kipps,et al.  Idiotypic and genetic studies of human rheumatoid factors. , 1987, Arthritis and rheumatism.

[58]  G. Kingsley,et al.  Abnormal distribution of the helper-inducer and suppressor-inducer T-lymphocyte subsets in the rheumatoid joint. , 1987, Clinical immunology and immunopathology.

[59]  P. Gregersen,et al.  The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. , 1987, Arthritis and rheumatism.

[60]  H. Yamanaka,et al.  Spontaneous production of an interleukin 1-like factor by cloned rheumatoid synovial cells in long-term culture. , 1987, The Journal of clinical investigation.

[61]  M. Weinblatt,et al.  Effects of dietary supplementation with marine fish oil on leukocyte lipid mediator generation and function in rheumatoid arthritis. , 1987, Arthritis and rheumatism.

[62]  P. Tugwell,et al.  Methotrexate in Rheumatoid Arthritis: Indications, Contraindications, Efficacy, and Safety , 1987 .

[63]  A. Basbaum,et al.  Contribution of the nervous system to the pathophysiology of rheumatoid arthritis and other polyarthritides. , 1987, Rheumatic diseases clinics of North America.

[64]  G. Kingsley,et al.  Expression of HLA-DR, DQ and DP antigens and interleukin-2 receptor on synovial fluid T lymphocyte subsets in rheumatoid arthritis: evidence for "frustrated" activation. , 1987, The Journal of rheumatology.

[65]  J. Heath,et al.  Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. , 1987, The EMBO journal.

[66]  O. Nielsen,et al.  Enhanced capacity for release of leucotriene B4 by neutrophils in rheumatoid arthritis. , 1987, Annals of the rheumatic diseases.

[67]  A. Silman,et al.  Articular indices of joint inflammation in rheumatoid arthritis. Correlation with the acute-phase response. , 1987, Arthritis and rheumatism.

[68]  D. Symmons,et al.  LONG-TERM OUTCOME OF TREATING RHEUMATOID ARTHRITIS: RESULTS AFTER 20 YEARS , 1987, The Lancet.

[69]  M. Stephenson,et al.  Stimulation of procollagenase synthesis parallels increases in cellular procollagenase mRNA in human articular chondrocytes exposed to recombinant interleukin 1 beta or phorbol ester. , 1987, Biochemical and biophysical research communications.

[70]  J. Kremer,et al.  Fish-oil fatty acid supplementation in active rheumatoid arthritis. A double-blinded, controlled, crossover study. , 1987, Annals of internal medicine.

[71]  R. Pinals.  Survival in rheumatoid arthritis. , 1987, Arthritis and rheumatism.

[72]  P. Henson,et al.  Tissue injury in inflammation. Oxidants, proteinases, and cationic proteins. , 1987, The Journal of clinical investigation.

[73]  D. Carson,et al.  Substance P activation of rheumatoid synoviocytes: neural pathway in pathogenesis of arthritis. , 1987, Science.

[74]  T. Benedek.  A century of American rheumatology. , 1987, Annals of internal medicine.

[75]  R. Jacoby,et al.  Human parvovirus infection in early rheumatoid and inflammatory arthritis. , 1986, Annals of the rheumatic diseases.

[76]  T. Pincus,et al.  Taking mortality in rheumatoid arthritis seriously--predictive markers, socioeconomic status and comorbidity. , 1986, The Journal of rheumatology.

[77]  L. Orci,et al.  Basic fibroblast growth factor induces angiogenesis in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[78]  A. Steere,et al.  A distinct endothelial cell recognition system that controls lymphocyte traffic into inflamed synovium. , 1986, Science.

[79]  C. Dinarello,et al.  Release of lymphokines after infection with Epstein Barr virus in vitro. II. A monocyte-dependent inhibitor of interleukin 1 downregulates the production of interleukin 2 and interferon-gamma in rheumatoid arthritis. , 1986, Journal of immunology.

[80]  M. Epstein,et al.  Disturbance of the Epstein-Barr virus-host balance in rheumatoid arthritis patients: a quantitative study. , 1986, Clinical and experimental immunology.

[81]  P. Junker,et al.  Serum amino-terminal type III procollagen peptide in rheumatoid arthritis. Relationship to disease activity, treatment, and development of joint erosions. , 1986, Arthritis and rheumatism.

[82]  E. D. Harris,et al.  Pathogenesis of rheumatoid arthritis. , 1986, The American journal of medicine.

[83]  R. Thompson,et al.  Primary structure and cDNA cloning of human fibroblast collagenase inhibitor. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[84]  A. Koch,et al.  Stimulation of neovascularization by human rheumatoid synovial tissue macrophages. , 1986, Arthritis and rheumatism.

[85]  J. Fries,et al.  The development of disability in rheumatoid arthritis. , 1986, Arthritis and rheumatism.

[86]  P. Gregersen,et al.  Molecular diversity of HLA-DR4 haplotypes , 1986 .

[87]  J. Massagué,et al.  Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. , 1986, The Journal of biological chemistry.

[88]  Z. Werb,et al.  Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors. , 1986, The Journal of biological chemistry.

[89]  M. Rowley,et al.  Collagen antibodies in rheumatoid arthritis. Significance of antibodies to denatured collagen and their association with HLA-DR4. , 1986, Arthritis and rheumatism.

[90]  C. Sledge,et al.  Treatment of rheumatoid synovitis of the knee with intraarticular injection of dysprosium 165-ferric hydroxide macroaggregates. , 1986, Arthritis and rheumatism.

[91]  D. Haskard,et al.  Interleukin 1 increases the binding of human B and T lymphocytes to endothelial cell monolayers. , 1986, Journal of immunology.

[92]  C. Yu,et al.  Human gamma interferon increases the binding of T lymphocytes to endothelial cells. , 1985, Clinical and experimental immunology.

[93]  J. Elmgreen,et al.  Subnormal sensitivity of neutrophils to complement split product C5a in rheumatoid arthritis: relation to complement catabolism and disease extent. , 1985, Annals of the rheumatic diseases.

[94]  R. Dwek,et al.  Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG , 1985, Nature.

[95]  M. Moskowitz,et al.  Hypothesis: the nervous system may contribute to the pathophysiology of rheumatoid arthritis. , 1985, The Journal of rheumatology.

[96]  D. Lubeck,et al.  Outcomes of self-help education for patients with arthritis. , 1985, Arthritis and rheumatism.

[97]  H. Jasin.  Autoantibody specificities of immune complexes sequestered in articular cartilage of patients with rheumatoid arthritis and osteoarthritis. , 1985, Arthritis and rheumatism.

[98]  A. Woolf,et al.  HUMAN PARVOVIRUS ARTHROPATHY , 1985, The Lancet.

[99]  A. Kang,et al.  Secretion of collagenolytic enzymes by human polymorphonuclear leukocytes. , 1984, Collagen and related research.

[100]  N. Talal,et al.  Characterization of the defective autologous mixed lymphocyte response in rheumatoid arthritis. , 1984, Arthritis and rheumatism.

[101]  H. Mcdevitt,et al.  Gene conversion between murine class II major histocompatibility complex loci. Functional and molecular evidence from the bm 12 mutant , 1984, The Journal of experimental medicine.

[102]  H. Valdimarsson,et al.  Prospective study of early rheumatoid arthritis. II. Association of rheumatoid factor isotypes with fluctuations in disease activity. , 1984, Annals of the rheumatic diseases.

[103]  Takako Sasaki,et al.  Serum Clq levels as a prognostic guide to articular erosions in patients with rheumatoid arthritis , 1984 .

[104]  R. Deitch.  Commentary from Westminster , 1984, The Lancet.

[105]  R. J. Boyd,et al.  Association of parvoviruses with rheumatoid arthritis of humans. , 1984, Science.

[106]  A. Newberg,et al.  Low dose prednisone therapy in rheumatoid arthritis: a double blind study. , 1983, The Journal of rheumatology.

[107]  H. Jasin.  Abnormalities of immune regulation in the connective tissue diseases. , 1983, Seminars in arthritis and rheumatism.

[108]  N. Zvaifler,et al.  Analysis of the defects responsible for the impaired regulation of EBV-induced B cell proliferation by rheumatoid arthritis lymphocytes. II. Role of monocytes and the increased sensitivity of rheumatoid arthritis lymphocytes to prostaglandin E. , 1983, Journal of immunology.

[109]  R. Winchester,et al.  Identification of Three Major Synovial Lining Cell Populations by Monoclonal Antibodies Directed to Ia Antigens and Antigens Associated with Monocytes/Macrophages and Fibroblasts , 1983, Scandinavian journal of immunology.

[110]  N. Zvaifler,et al.  Analysis of the defects responsible for the impaired regulation of Epstein-Barr virus-induced B cell proliferation by rheumatoid arthritis lymphocytes. I. Diminished gamma interferon production in response to autologous stimulation , 1983, The Journal of experimental medicine.

[111]  M. Shipley,et al.  A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF METHYLPREDNISOLONE PULSE THERAPY IN ACTIVE RHEUMATOID DISEASE , 1982, The Lancet.

[112]  J. Fries,et al.  An analysis of the American Rheumatism Association criteria for rheumatoid arthritis. , 1982, Arthritis and rheumatism.

[113]  D. Katz,et al.  Immunoglobulin E-rheumatoid factor in the serum of patients with rheumatoid arthritis, asthma, and other diseases. , 1981, The Journal of clinical investigation.

[114]  S. Silverman,et al.  Antibodies to Epstein—Barr Viral Antigens in Early Rheumatoid Arthritis , 1981 .

[115]  N. Zvaifler,et al.  Epstein‐barr virus , 1981 .

[116]  E. Lennette,et al.  Elevated levels of antibodies to Epstein-Barr virus antigens in sera and synovial fluids of patients with rheumatoid arthritis. , 1981, The Journal of clinical investigation.

[117]  M. A. Bray,et al.  Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes , 1980, Nature.

[118]  S. Shiozawa,et al.  Absence of immunoglobulins in rheumatoid cartilage-pannus junctions. , 1980, Arthritis and rheumatism.

[119]  F. Jensen,et al.  In vitro effects of Epstein-Barr virus on peripheral blood mononuclear cells from patients with rheumatoid arthritis and normal subjects , 1978, The Journal of experimental medicine.

[120]  D. Woolley,et al.  Collagenase immunolocalization in cultures of rheumatoid synovial cells. , 1978, Science.

[121]  P. Henson,et al.  Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions. , 1978, Journal of immunology.

[122]  Z. Werb,et al.  Endogenous activation of latent collagenase by rheumatoid synovial cells. Evidence for a role of plasminogen activator. , 1977, The New England journal of medicine.

[123]  L. V. D. van de Putte,et al.  Activators and inhibitors of fibrinolysis in rheumatoid and nonrheumatoid synovial membranes. A histochemical study. , 1977, Arthritis and rheumatism.

[124]  M. Corbett,et al.  Early rheumatoid disease. II. Patterns of joint involvement. , 1976, Annals of the rheumatic diseases.

[125]  J M Crown,et al.  Early rheumatoid disease. I. Onset. , 1976, Annals of the rheumatic diseases.

[126]  R. Hutchinson,et al.  Thrombocytosis in rheumatoid arthritis. , 1976, Annals of the rheumatic diseases.

[127]  H. J. Goldsmith,et al.  RE-USE OF DISPOSABLE DIALYSERS , 1976, The Lancet.

[128]  S. Paget,et al.  Predominantly T-cell infiltrate in rheumatoid synovial membranes. , 1975, The New England journal of medicine.

[129]  E. D. Harris,et al.  Collagenolytic systems in rheumatoid arthritis. , 1975, Clinical orthopaedics and related research.

[130]  G. Weissmann,et al.  Generation of C5-derived lysosomal enzyme-releasing activity (C5a) by lysates of leukocyte lysosomes. , 1974, Journal of immunology.

[131]  J. A. Mills.  Nonsteroidal Anti-Inflammatory Drugs , 1974 .

[132]  R. Pope,et al.  The molecular basis of self-association of antibodies to IgG (rheumatoid factors) in rheumatoid arthritis. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[133]  M. Jayson,et al.  Onset, Early Stages, and Prognosis of Rheumatoid Arthritis: A Clinical Study of 100 Patients with 11-year Follow-up , 1973, British medical journal.

[134]  R. Winchester,et al.  Observations on the eosinophilia of certain patients with rheumatoid arthritis. , 1971, Arthritis and rheumatism.

[135]  W. Creasey,et al.  Granulocyte survival in synovial exudate of patients with rheumatoid arthritis and other inflammatory joint diseases. , 1967, The Yale journal of biology and medicine.

[136]  H. M. Rose,et al.  Differential Agglutination of Normal and Sensitized Sheep Erythrocytes by Sera of Patients with Rheumatoid Arthritis , 1948, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[137]  D. Stage,et al.  HLA genes associated with rheumatoid arthritis. Identification of susceptibility alleles using specific oligonucleotide probes. , 1989, Arthritis and rheumatism.

[138]  J. Dayer,et al.  Natural inhibitors and antagonists of interleukin-1 , 1989 .

[139]  D. Schurman,et al.  Dissection of the mechanisms of immune injury in rheumatoid arthritis, using total lymphoid irradiation. , 1988, Arthritis and rheumatism.

[140]  Phillips Pe.  Evidence implicating infectious agents in rheumatoid arthritis and juvenile rheumatoid arthritis. , 1988 .

[141]  H. Mcdevitt,et al.  The immunogenetics of rheumatic diseases. , 1988, Bulletin on the rheumatic diseases.

[142]  T. Pincus,et al.  Rheumatoid arthritis: disappointing long-term outcomes despite successful short-term clinical trials. , 1988, Journal of clinical epidemiology.

[143]  R. Pope,et al.  Increased helper inducer and decreased suppressor inducer phenotypes in the rheumatoid joint. , 1988, Arthritis and rheumatism.

[144]  M. Segall,et al.  Dw subtypes of DR4 in rheumatoid arthritis: evidence for a preferential association with Dw4. , 1986, Human immunology.

[145]  A. Kang,et al.  Collagen autoimmune arthritis. , 1984, Annual review of immunology.

[146]  J. Clot,et al.  Immunomodulating effect of human placenta-eluted gamma globulins in rheumatoid arthritis. , 1982, Arthritis and rheumatism.